Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | JAM2 |
| Upstream (Parents) |
|---|
| (<<) CNRIP1 → JAM2 |
| (<<) LHFP → JAM2 |
| (<<) CXCL12 → JAM2 |
| (<<) SPARCL1 → JAM2 |
| Downstream (Children) |
|---|
| JAM2 → RUNDC3B (>>) |
| JAM2 → PDE7B (>>) |
| JAM2 → MAST4 (>>) |
| JAM2 → LPAR6 (>>) |
| JAM2 → LRRN3 (>>) |
| JAM2 → SHE (>>) |
| JAM2 → SAP18 (>>) |
| JAM2 → GPRASP1 (>>) |
| JAM2 → LHFP (>>) |
| JAM2 → CCL28 (>>) |
| JAM2 → CLDN11 (>>) |
| JAM2 → NBEA (>>) |
| JAM2 → SLIT2 (>>) |
| JAM2 → COL6A6 (>>) |
| JAM2 → CXCL12 (>>) |
| JAM2 → TCEAL7 (>>) |
| JAM2 → PID1 (>>) |
| JAM2 → TAC1 (>>) |
| JAM2 → PGR (>>) |
| JAM2 → SDPR (>>) |
